Developer docs
API playgroundTry for free, no card

Search company profiles

HistoGenetics

Full company profile

uuid000cmiy

Namestring
HistoGenetics
Legal namestring
HistoGenetics LLC
Company typeenum
Private
Founded yearint
2006
Descriptiontext

HistoGenetics is a privately held, CLIA-certified high-complexity clinical laboratory founded in 2006 in Ossining, New York, specializing in immunogenetics and genomic services. Its core offering is HLA sequence-based typing (SBT) for classical HLA genes (A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1, DPB1) and non-classical HLA (E, G, MICA, MICB, DRA), delivered at five resolution tiers (1x through 8x). The company serves donor registries, transplant centers, HLA laboratories, cord blood centers, donor centers, hospitals, pharmacogenomics programs, and research institutions worldwide, and reports having processed millions of HLA SBT tests since founding.

The technology stack spans Illumina MiSeq/NovaSeq for short-read NGS, the largest known global fleet of PacBio Sequel II/IIe instruments for SMRT long-read sequencing, Oxford Nanopore GridION for third-generation sequencing, BioNano Saphyr for optical whole genome mapping, and 10x Genomics Chromium for single-cell applications. Beyond HLA, the company offers KIR gene typing, FCGR genotyping, molecular ABO Rh typing, CCR5 Δ32 detection, HPA platelet antigen genotyping, CMV IgG detection, T cell receptor repertoire analysis, hemoglobin beta gene sequencing, engraftment monitoring, pharmacogenomics testing, FDA EUA COVID-19 qRT-PCR, whole genome sequencing, Iso-Seq, single-cell, microbiome, RNA-seq, and microarray services. The portfolio is delivered through a multi-module client portal with configurable report delivery via FTP, ShareFile, email, and HTTP.

The business is a transaction-based laboratory services model with quote-based pricing and tiered turnaround (3 days for ultra-urgent clinical samples, 5-8 days for standard clinical, 14-28 days for registry/research), with volume and frequency discounts for large organizations. Distribution is direct enterprise field sales and inside sales targeting healthcare and research institutions globally. The company is led by founders Dr. Soo Young Yang (Chairman, 35+ years HLA genetics research at Memorial Sloan-Kettering) and Dr. Nezih Cereb (CEO, clinical HLA typing and bone marrow transplantation expert), and is accredited by ASHI, certified under CLIA, ISO/IEC 27001:2022, and SOC 2 Type II. No institutional investors, parent company, or public funding history is disclosed.

Short descriptiontext

HistoGenetics is a private, CLIA-certified clinical laboratory founded in 2006 that provides HLA sequence-based typing, pharmacogenomics, and advanced genomic sequencing services to donor registries, transplant centers, hospitals, and research institutions globally, operating the largest fleet of PacBio Sequel II instruments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersOssining, United States
HQ citystring
Ossining
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
HLA typing services, immunogenetics testing, genomic sequencing services, pharmacogenomics testing, transplant matching
Industry5 codes
PRIMARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Immunogenetics & Genomic Testing Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model7 records
1HLA Typing Services
TypeTransaction Fee
Description

High-resolution HLA tissue typing for donor registries, transplant centers, and clinical laboratories. Services include classical HLA (A, B, C, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, DPB1), non-classical HLA (E, G, MICA, MICB, DRA), and multiple resolution levels from 1x to 8x.

histogenetics.com
2KIR Gene Typing
TypeTransaction Fee
Description

KIR Gene Content Typing on Illumina platform and KIR 3DL1, 3DS1 Gene Allele level typing on PacBio platform.

histogenetics.com
3Pharmacogenomics Testing
TypeTransaction Fee
Description

CLIA and New York State approved pharmacogenomics testing services for predicting individual medication responses.

histogenetics.com
4Genomic Sequencing Services
TypeTransaction Fee
Description

Whole genome sequencing, RNA-Sequencing, single-cell sequencing, microbiome sequencing, optical whole genome mapping, and microarray services.

histogenetics.com
5Molecular ABO Rh Typing
TypeTransaction Fee
Description

Molecular serotype prediction for ABO and Rh blood groups (research purpose only).

histogenetics.com
6COVID-19 Testing
TypeTransaction Fee
Description

Viral diagnostic testing for businesses, schools, and organizations under FDA Emergency Use Authorization.

histogenetics.com
7Additional Genetic Tests
TypeTransaction Fee
Description

CCR5 delta 32 detection, HPA-1a/HPA-1b Human Platelet Antigen Genotyping, CMV IgG detection, T Cell Receptor Repertoire analysis, Hemoglobin Beta Gene sequencing, and engraftment monitoring.

histogenetics.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales
Pricing details3 tiers
1Clinical samples with ultra-urgent turnaround (3 days)
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

3 working days turnaround for ultra urgent clinical samples - premium pricing tier

histogenetics.com
2Clinical samples with urgent turnaround (5-8 days)
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

5-8 working days turnaround for urgent and standard clinical samples - standard pricing tier

histogenetics.com
3Registry and research samples (14-28 days)
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

14-28 calendar days turnaround for registry and research typing samples - volume pricing available

histogenetics.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

HistoGenetics provides HLA sequence-based typing (SBT) and a broader suite of immunogenetics, pharmacogenomics, and genomic sequencing services delivered through its CLIA-certified, high-complexity laboratory. Services include high-resolution HLA typing for classical and non-classical genes at multiple resolution levels (1x–8x), KIR and FCGR genotyping, molecular ABO Rh typing, engraftment monitoring, CLIA-approved pharmacogenomics testing, FDA EUA COVID-19 testing, and advanced sequencing (whole genome, single-cell, microbiome, optical mapping, RNA-Seq, microarray) for donor registries, transplant centers, HLA laboratories, cord blood centers, hospitals, and research institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100% concordance in ABO Rh algorithm validation study with 1000 Caucasian individuals
+2 more records
Product overview1 text field

HistoGenetics provides a unified suite of immunogenetics and genomics services centered on HLA sequence-based typing (SBT) as the core product. The portfolio spans five main pillars: (1) HLA Typing Services — offering classical HLA genes (A, B, C, DRB1/3/4/5, DQA1, DQB1, DPA1, DPB1) and non-classical HLA (E, G, MICA, MICB, DRA) at five resolution tiers (1x through 8x); (2) Specialized Immunogenetics sub-products including KIR gene typing, FCGR genotyping, molecular ABO Rh typing, CCR5 Δ32 detection, HPA platelet antigen genotyping, CMV IgG detection, TCR repertoire analysis, and hemoglobin beta gene sequencing; (3) Pharmacogenomics (PGX) testing — a CLIA/NY State-approved full-panel service; (4) COVID-19 testing via FDA EUA qRT-PCR; and (5) Advanced Genomic Sequencing Services including whole genome sequencing (PacBio HiFi, Illumina NovaSeq), Iso-Seq, single cell sequencing (10x Genomics), microbiome sequencing, optical genome mapping (BioNano Saphyr), RNA-seq, and microarray genotyping. Services are delivered through a multi-module client portal (clients.histogenetics.com) with configurable reporting formats (PDF, XLS, XML, TXT, HML, HGX) and delivery via FTP, ShareFile, email, or HTTP.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or Integration
Description

Uses Illumina MiSeq and NovaSeq platforms for NGS-based HLA typing and genomic sequencing services. Provides high-throughput short-read sequencing capability for routine HLA testing and population-scale genetics studies.

Strategic tierCoreTypeTechnology or Integration
Description

Operates largest fleet of Sequel II, Sequel IIe, and Sequel I instruments for SMRT sequencing. Uses PacBio Sequel and Revio platforms for whole gene HLA typing, KIR allele-level typing, and whole genome sequencing. Set the Gold Standard for HLA typing using SMRT technology.

Strategic tierSupportingTypeTechnology or Integration
Description

Uses Oxford Nanopore GridION and P2 Solo platforms for third-generation sequencing capabilities, enabling long-read sequencing for genomic analysis.

Strategic tierSupportingTypeTechnology or Integration
Description

Operates BioNano Saphyr system for optical whole genome mapping. Enables identification of structural variations and analysis of complex genetic regions through ultra-high molecular weight DNA extraction, labeling, and imaging.

Strategic tierSupportingTypeTechnology or Integration
Description

Uses 10x Genomics Chromium platform for single-cell RNA sequencing, single-cell immuno-profiling, and single-cell ATAC-Seq analysis on Illumina sequencing platforms.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large global genomic services provider with broad sequencing, HLA, and specialty lab offerings. Overlaps with HistoGenetics' genomic sequencing services menu at greater scale and broader portfolio.

TypeEmerging player
Description

Specialty molecular diagnostics company focused on PCR-based and NGS-based genetic testing reagents. Comparable in niche molecular genetic test development relevant to HistoGenetics' specialty testing portfolio.

TypeDirect peer
Description

Transplant-focused diagnostics company offering AlloSure and AlloMap testing for post-transplant monitoring. Comparable as a specialty diagnostics provider in the transplant care continuum where HistoGenetics offers engraftment monitoring and HLA typing.

4One Lambda (Thermo Fisher Scientific)
TypeDirect peer
Description

Direct peer in HLA typing reagents, kits, and laboratory services for transplant immunogenetics. Competes head-to-head with HistoGenetics in donor registry and transplant-center HLA testing workflows.

TypeBroad incumbent
Description

National clinical and specialty laboratory with pharmacogenomics, HLA, and genomic testing capabilities. Comparable as a CLIA-certified lab offering specialty genetic testing to enterprise healthcare customers.

6Sema4 (now part of GeneDx)
TypeBroad incumbent
Description

Clinical genomics company offering hereditary, reproductive, and somatic genetic testing at scale. Comparable as a broad clinical genomics service provider adjacent to HistoGenetics' specialty HLA/molecular diagnostics.

TypeDirect peer
Description

Direct peer specializing in NGS-based HLA and KIR typing reagents and software. Competes with HistoGenetics in HLA sequencing-based typing services and SBT reagent markets.

TypeDirect peer
Description

Specialty transfusion and transplant diagnostics provider including molecular HLA and blood-group reagents. Comparable in molecular immunogenetics and blood-group typing product lines served by HistoGenetics.

TypeBroad incumbent
Description

Major clinical diagnostics network offering HLA typing, pharmacogenomics, and advanced genomic sequencing. Comparable in delivering CLIA-certified specialty genetics services to hospitals and transplant programs.

TypeBroad incumbent
Description

Clinical genetic testing company specializing in transplant monitoring (Prospera) and reproductive/oncology genomics. Comparable as a specialty genomic testing provider with transplant-monitoring overlap.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HistoGenetics

Immunogenetics & Genomic Testing Serviceshistogenetics.com

HistoGenetics is a private, CLIA-certified clinical laboratory founded in 2006 that provides HLA sequence-based typing, pharmacogenomics, and advanced genomic sequencing services to donor registries, transplant centers, hospitals, and research institutions globally, operating the largest fleet of PacBio Sequel II instruments.

What HistoGenetics does

HistoGenetics is a privately held, CLIA-certified high-complexity clinical laboratory founded in 2006 in Ossining, New York, specializing in immunogenetics and genomic services. Its core offering is HLA sequence-based typing (SBT) for classical HLA genes (A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1, DPB1) and non-classical HLA (E, G, MICA, MICB, DRA), delivered at five resolution tiers (1x through 8x). The company serves donor registries, transplant centers, HLA laboratories, cord blood centers, donor centers, hospitals, pharmacogenomics programs, and research institutions worldwide, and reports having processed millions of HLA SBT tests since founding.

The technology stack spans Illumina MiSeq/NovaSeq for short-read NGS, the largest known global fleet of PacBio Sequel II/IIe instruments for SMRT long-read sequencing, Oxford Nanopore GridION for third-generation sequencing, BioNano Saphyr for optical whole genome mapping, and 10x Genomics Chromium for single-cell applications. Beyond HLA, the company offers KIR gene typing, FCGR genotyping, molecular ABO Rh typing, CCR5 Δ32 detection, HPA platelet antigen genotyping, CMV IgG detection, T cell receptor repertoire analysis, hemoglobin beta gene sequencing, engraftment monitoring, pharmacogenomics testing, FDA EUA COVID-19 qRT-PCR, whole genome sequencing, Iso-Seq, single-cell, microbiome, RNA-seq, and microarray services. The portfolio is delivered through a multi-module client portal with configurable report delivery via FTP, ShareFile, email, and HTTP.

The business is a transaction-based laboratory services model with quote-based pricing and tiered turnaround (3 days for ultra-urgent clinical samples, 5-8 days for standard clinical, 14-28 days for registry/research), with volume and frequency discounts for large organizations. Distribution is direct enterprise field sales and inside sales targeting healthcare and research institutions globally. The company is led by founders Dr. Soo Young Yang (Chairman, 35+ years HLA genetics research at Memorial Sloan-Kettering) and Dr. Nezih Cereb (CEO, clinical HLA typing and bone marrow transplantation expert), and is accredited by ASHI, certified under CLIA, ISO/IEC 27001:2022, and SOC 2 Type II. No institutional investors, parent company, or public funding history is disclosed.

HistoGenetics firmographics

Firmographics
Name
HistoGenetics
Legal name
HistoGenetics LLC
Website
https://histogenetics.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
101–250 employees
Short description
HistoGenetics is a private, CLIA-certified clinical laboratory founded in 2006 that provides HLA sequence-based typing, pharmacogenomics, and advanced genomic sequencing services to donor registries, transplant centers, hospitals, and research institutions globally, operating the largest fleet of PacBio Sequel II instruments.
Ownership category
akta.pro rank

HistoGenetics industry classification

Industry
Product category
Immunogenetics & Genomic Testing Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • HLA typing services
  • Immunogenetics testing
  • Genomic sequencing services
  • Pharmacogenomics testing
  • Transplant matching

Where HistoGenetics is headquartered

Location

Headquarters

HQ city
Ossining
HQ country
United States
HQ region
North America

Offices1 record

Markets served

HistoGenetics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. HLA Typing Services: High-resolution HLA tissue typing for donor registries, transplant centers, and clinical laboratories. Services include classical HLA (A, B, C, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, DPB1), non-classical HLA (E, G, MICA, MICB, DRA), and multiple resolution levels from 1x to 8x.
  2. KIR Gene Typing: KIR Gene Content Typing on Illumina platform and KIR 3DL1, 3DS1 Gene Allele level typing on PacBio platform.
  3. Pharmacogenomics Testing: CLIA and New York State approved pharmacogenomics testing services for predicting individual medication responses.
  4. Genomic Sequencing Services: Whole genome sequencing, RNA-Sequencing, single-cell sequencing, microbiome sequencing, optical whole genome mapping, and microarray services.
  5. Molecular ABO Rh Typing: Molecular serotype prediction for ABO and Rh blood groups (research purpose only).
  6. COVID-19 Testing: Viral diagnostic testing for businesses, schools, and organizations under FDA Emergency Use Authorization.
  7. Additional Genetic Tests: CCR5 delta 32 detection, HPA-1a/HPA-1b Human Platelet Antigen Genotyping, CMV IgG detection, T Cell Receptor Repertoire analysis, Hemoglobin Beta Gene sequencing, and engraftment monitoring.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goClinical samples with ultra-urgent turnaround (3 days)
Transaction based/ take ratePay-as-you-goClinical samples with urgent turnaround (5-8 days)
Transaction based/ take ratePay-as-you-goRegistry and research samples (14-28 days)

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

HistoGenetics product offering

Product offering

Core offering

HistoGenetics provides HLA sequence-based typing (SBT) and a broader suite of immunogenetics, pharmacogenomics, and genomic sequencing services delivered through its CLIA-certified, high-complexity laboratory. Services include high-resolution HLA typing for classical and non-classical genes at multiple resolution levels (1x–8x), KIR and FCGR genotyping, molecular ABO Rh typing, engraftment monitoring, CLIA-approved pharmacogenomics testing, FDA EUA COVID-19 testing, and advanced sequencing (whole genome, single-cell, microbiome, optical mapping, RNA-Seq, microarray) for donor registries, transplant centers, HLA laboratories, cord blood centers, hospitals, and research institutions.

Product overview

HistoGenetics provides a unified suite of immunogenetics and genomics services centered on HLA sequence-based typing (SBT) as the core product. The portfolio spans five main pillars: (1) HLA Typing Services — offering classical HLA genes (A, B, C, DRB1/3/4/5, DQA1, DQB1, DPA1, DPB1) and non-classical HLA (E, G, MICA, MICB, DRA) at five resolution tiers (1x through 8x); (2) Specialized Immunogenetics sub-products including KIR gene typing, FCGR genotyping, molecular ABO Rh typing, CCR5 Δ32 detection, HPA platelet antigen genotyping, CMV IgG detection, TCR repertoire analysis, and hemoglobin beta gene sequencing; (3) Pharmacogenomics (PGX) testing — a CLIA/NY State-approved full-panel service; (4) COVID-19 testing via FDA EUA qRT-PCR; and (5) Advanced Genomic Sequencing Services including whole genome sequencing (PacBio HiFi, Illumina NovaSeq), Iso-Seq, single cell sequencing (10x Genomics), microbiome sequencing, optical genome mapping (BioNano Saphyr), RNA-seq, and microarray genotyping. Services are delivered through a multi-module client portal (clients.histogenetics.com) with configurable reporting formats (PDF, XLS, XML, TXT, HML, HGX) and delivery via FTP, ShareFile, email, or HTTP.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 100% concordance in ABO Rh algorithm validation study with 1000 Caucasian individuals
  • +2 more outcomes

Companies that use HistoGenetics

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles5 records

HistoGenetics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

HistoGenetics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and supporting.

  • IlluminacoreTechnology or IntegrationUses Illumina MiSeq and NovaSeq platforms for NGS-based HLA typing and genomic sequencing services. Provides high-throughput short-read sequencing capability for routine HLA testing and population-scale genetics studies.
  • Pacific BiosciencescoreTechnology or IntegrationOperates largest fleet of Sequel II, Sequel IIe, and Sequel I instruments for SMRT sequencing. Uses PacBio Sequel and Revio platforms for whole gene HLA typing, KIR allele-level typing, and whole genome sequencing. Set the Gold Standard for HLA typing using SMRT technology.
  • Oxford Nanopore TechnologiessupportingTechnology or IntegrationUses Oxford Nanopore GridION and P2 Solo platforms for third-generation sequencing capabilities, enabling long-read sequencing for genomic analysis.
  • BioNano GenomicssupportingTechnology or IntegrationOperates BioNano Saphyr system for optical whole genome mapping. Enables identification of structural variations and analysis of complex genetic regions through ultra-high molecular weight DNA extraction, labeling, and imaging.
  • 10x GenomicssupportingTechnology or IntegrationUses 10x Genomics Chromium platform for single-cell RNA sequencing, single-cell immuno-profiling, and single-cell ATAC-Seq analysis on Illumina sequencing platforms.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

HistoGenetics competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Genomics: Large global genomic services provider with broad sequencing, HLA, and specialty lab offerings. Overlaps with HistoGenetics' genomic sequencing services menu at greater scale and broader portfolio.
  • Labcorp: National clinical and specialty laboratory with pharmacogenomics, HLA, and genomic testing capabilities. Comparable as a CLIA-certified lab offering specialty genetic testing to enterprise healthcare customers.
  • Sema4 (now part of GeneDx): Clinical genomics company offering hereditary, reproductive, and somatic genetic testing at scale. Comparable as a broad clinical genomics service provider adjacent to HistoGenetics' specialty HLA/molecular diagnostics.
  • Quest Diagnostics: Major clinical diagnostics network offering HLA typing, pharmacogenomics, and advanced genomic sequencing. Comparable in delivering CLIA-certified specialty genetics services to hospitals and transplant programs.
  • Natera: Clinical genetic testing company specializing in transplant monitoring (Prospera) and reproductive/oncology genomics. Comparable as a specialty genomic testing provider with transplant-monitoring overlap.

Emerging players

  • Asuragen: Specialty molecular diagnostics company focused on PCR-based and NGS-based genetic testing reagents. Comparable in niche molecular genetic test development relevant to HistoGenetics' specialty testing portfolio.

Direct peers

  • CareDx: Transplant-focused diagnostics company offering AlloSure and AlloMap testing for post-transplant monitoring. Comparable as a specialty diagnostics provider in the transplant care continuum where HistoGenetics offers engraftment monitoring and HLA typing.
  • One Lambda (Thermo Fisher Scientific): Direct peer in HLA typing reagents, kits, and laboratory services for transplant immunogenetics. Competes head-to-head with HistoGenetics in donor registry and transplant-center HLA testing workflows.
  • GenDx: Direct peer specializing in NGS-based HLA and KIR typing reagents and software. Competes with HistoGenetics in HLA sequencing-based typing services and SBT reagent markets.
  • Immucor: Specialty transfusion and transplant diagnostics provider including molecular HLA and blood-group reagents. Comparable in molecular immunogenetics and blood-group typing product lines served by HistoGenetics.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

HistoGenetics social profiles

Digital presence

HistoGenetics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HistoGenetics leadership team

Management profile

Number of profiles

Profiles2 records

HistoGenetics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HistoGenetics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HistoGenetics

What does HistoGenetics do?

HistoGenetics provides HLA sequence-based typing (SBT) and a broader suite of immunogenetics, pharmacogenomics, and genomic sequencing services delivered through its CLIA-certified, high-complexity laboratory. Services include high-resolution HLA typing for classical and non-classical genes at multiple resolution levels (1x–8x), KIR and FCGR genotyping, molecular ABO Rh typing, engraftment monitoring, CLIA-approved pharmacogenomics testing, FDA EUA COVID-19 testing, and advanced sequencing (whole genome, single-cell, microbiome, optical mapping, RNA-Seq, microarray) for donor registries, transplant centers, HLA laboratories, cord blood centers, hospitals, and research institutions.

Is HistoGenetics a public or private company?

HistoGenetics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was HistoGenetics founded?

HistoGenetics was founded in 2006. It employs 101 to 250 people.

Where is HistoGenetics based?

HistoGenetics is headquartered in Ossining, United States, in the North America region.

How does HistoGenetics make money?

Seven revenue lines are on record. HLA Typing Services are the primary driver. The others are KIR Gene Typing, pharmacogenomics Testing, genomic Sequencing Services, molecular ABO Rh Typing, COVID-19 Testing and additional Genetic Tests.

Who are HistoGenetics's main competitors?

Broad incumbents on record are Eurofins Genomics, Labcorp, Sema4 (now part of GeneDx), Quest Diagnostics and Natera. Asuragen is listed as an emerging player. Direct peers are CareDx, One Lambda (Thermo Fisher Scientific), GenDx and Immucor.

Does HistoGenetics have an API?

No public API is recorded for HistoGenetics.

What industry is HistoGenetics in?

HistoGenetics's product category is Immunogenetics & Genomic Testing Services. Its primary akta.pro industry code is HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support), with a secondary code of HLAAAMAJ, Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals